http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
BIOLASE to Present at the Summer Solstice Best Ideas From the Buy Side Conference on June 2, 2021
-
BIOLASE Hosts Pediatric Dental Laser Training with Healthy Smiles for Kids of Orange County
-
BIOLASE Reports 70% Revenue Growth In First Quarter 2021; Continued High Demand From New Users For Dental Lasers
-
BIOLASE, Inc to Report First Quarter 2021 Results on May 13, 2021
-
BIOLASE Announces the Launch of Waterlase Pediatric Dental Academy
-
BIOLASE Urges Stockholders To Vote "FOR" ALL Proposals At Upcoming Annual Meeting
-
BIOLASE and EdgeEndo Announce Plans to Develop New EdgePRO Laser-Assisted Microfluidic Irrigation Device for Endodontists
-
BIOLASE Announces Collaboration with Einstein Healthcare Network's Residency in Endodontics
-
BIOLASE Reports 31% Sequential Revenue Growth In 2020 Fourth Quarter; Demand From New Users Driving Positive Performance
-
BIOLASE, Inc. to Report Fourth Quarter and Full Year 2020 Results on March 25, 2021
-
BIOLASE To Participate In Maxim Group's Inaugural 2021 Emerging Growth Virtual Investor Conference
-
BIOLASE Announces the Launch of Waterlase Perio Academy
-
BIOLASE To Participate In H.C. Wainwright Investor Conference
-
Biolase (BIOL) Announces John R. Beaver Promoted To President And Chief Executive Officer
-
John R. Beaver Promoted To President And Chief Executive Officer Of BIOLASE; Will Leverage Dental Knowledge And Management Expertise To Achieve Growth Objectives
-
BIOLASE, Inc. Announces Closing Of $14.4 Million Bought Offering
-
BIOLASE, Inc. Announces Pricing of $14.4 Million Bought Deal Offering
-
BIOLASE Regains Compliance With Nasdaq Minimum Bid Price Requirement And Cancels Special Meeting Of Stockholders
-
BIOLASE Urges Stockholders To Vote Today "FOR" The Reverse Stock Split
-
BIOLASE Announces Preliminary Fourth Quarter Revenue Results And Current Cash Position
-
BIOLASE Announces Agreement With DSO Dental Care Alliance To Expand Laser Adoption In Dental Offices Across The United States
-
BIOLASE To Present At The H.C. Wainwright's BIOCONNECT 2021 Investor Conference
-
BIOLASE Announces Exclusive Collaboration with BMW Performance Center West
-
BIOLASE To Present At The 13th Annual LD Micro Main Event Conference
-
BIOLASE Announces the Launch of Waterlase Endo Academy
-
BIOLASE to Participate at the Benchmark Company Discovery One on One Investor Conference on November 18, 2020
-
BIOLASE Reports Strong Sequential Revenue Growth In Third Quarter 2020
-
BIOLASE, Inc. to Report Third Quarter 2020 Results on November 12, 2020
-
BIOLASE Announces Launch On M-Vest
-
BIOLASE Announces Preliminary Third Quarter Revenue Results; Reopening Of Dental Practices Drives Sequential Revenue Growth
-
BIOLASE To Host Expert Panel Webinar On The Advantages Of Using Laser Dentistry In The Current Healthcare Environment; Dental Practices Resuming Normal Operations As Procedure Volumes Reach 70% Of Pre
-
BIOLASE Hosts Nearly 400 Dental Professionals During Webinar On Landmark Study On Lasers And Managing Periodontitis
-
BIOLASE To Present At H.C. Wainwright's 22nd Annual Global Investor Conference
-
BIOLASE to Highlight Progress and Recent Achievements at the Colliers & Co. Institutional Investor Conference
-
BIOLASE to Present at the LD Micro 500 Virtual Conference
-
Biolase (BIOL) Regains Nasdaq Compliance For Minimum Stockholder Equity
-
BIOLASE Regains Nasdaq Compliance For Minimum Stockholder Equity
-
BIOLASE Reports Second Quarter 2020 Financial Results
-
BIOLASE, Inc. to Report Second Quarter 2020 Results on August 13, 2020
-
BIOLASE Announces Closing Of Oversubscribed Rights Offering
-
BIOLASE Announces Expiration Of Oversubscribed Rights Offering
-
Landmark Head-to-Head Study Published in Journal of Periodontology Concludes That BIOLASE REPAIRĀ® Perio Protocol is Superior for Procedure Time and Patient-Reported Outcomes
-
BIOLASE to Present at COVID-19 Webinar Hosted by Maxim Group on July 16, 2020
-
Biolase (BIOL) Announces Epic Hygiene Laser Meets Guidelines to Minimize Risk of COVID-19 Transmission
-
BIOLASE's Epic Hygiene Laser Meets Guidelines to Minimize Risk of COVID-19 Transmission
-
Biolase (BIOL) Announces Commencement of Rights Offering Subscription Period
-
BIOLASE, Inc. Announces Commencement of Rights Offering Subscription Period
-
Paragonix Technologies Announces Appointment of Alexander K. Arrow, MD, CFA to the Board of Directors
-
BIOLASE, Inc. Informs Stockholders of Key Dates and Terms Related to Announced Rights Offering
-
BIOLASE, Inc. Announces Closing of $6.9 Million Registered Direct Offering Priced At-The-Market

